Norbert G. Riedel, a director at Jazz Pharmaceuticals plc (JAZZ), made one open market sale of JAZZ shares in the last year, totaling about $656 thousand. His most recent sale occurred on February 27, 2026. Among 11,678 insiders with sales, Riedel's activity ranks 5,899th by value, well below the average of $8.6 million across roughly 6.4 transactions per insider. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Jazz Pharmaceuticals plc | $JAZZ | RIEDEL NORBERT G | Director | S | Ordinary Shares | 3415 | $192.00 | 17,654.0000 | 61,606,000 | 16.21% | 0.01% |
| Feb. 27, 2026 | Jazz Pharmaceuticals plc | $JAZZ | RIEDEL NORBERT G | Director | M | Non-Qualified Stock Option (right to buy) | 3415 | $0.00 | 0.0000 | 61,606,000 | 100.00% | 0.01% |
| Feb. 27, 2026 | Jazz Pharmaceuticals plc | $JAZZ | RIEDEL NORBERT G | Director | M | Ordinary Shares | 3415 | $138.08 | 21,069.0000 | 61,606,000 | 19.34% | 0.01% |
| Feb. 3, 2026 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | X | Common Stock | 30000 | $4.42 | 192,145.0000 | 26,893,000 | 18.50% | 0.11% |
| Feb. 3, 2026 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | X | Employee Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 26,893,000 | 100.00% | 0.11% |
| Jan. 12, 2026 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | A | Restricted Stock Units | 7757 | $0.00 | 294,253.0000 | 26,893,000 | 2.71% | 0.03% |
| Jan. 12, 2026 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | A | Employee Stock Option (Right to Buy) | 12196 | $0.00 | 286,496.0000 | 26,893,000 | 4.45% | 0.05% |
| Aug. 7, 2025 | Jazz Pharmaceuticals plc | $JAZZ | RIEDEL NORBERT G | Director | A | Ordinary Shares | 3507 | $0.00 | 19,459.0000 | 66,007,000 | 21.98% | 0.01% |
| Aug. 8, 2025 | Jazz Pharmaceuticals plc | $JAZZ | RIEDEL NORBERT G | Director | F | Ordinary Shares | 1805 | $111.25 | 17,654.0000 | 66,007,000 | 9.28% | 0.00% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | M | Employee Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 25,895,086 | 100.00% | 0.10% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | A | Employee Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 25,895,086 | 9999.99% | 0.10% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | M | Employee Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 25,895,086 | 100.00% | 0.19% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | M | Employee Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 25,895,086 | 100.00% | 0.11% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | M | Common Stock | 25000 | $3.47 | 162,145.0000 | 25,895,086 | 18.23% | 0.10% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | M | Common Stock | 50000 | $3.78 | 137,145.0000 | 25,895,086 | 57.38% | 0.19% |
| Jan. 3, 2025 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | M | Common Stock | 27400 | $3.58 | 87,145.0000 | 25,895,086 | 45.86% | 0.11% |
| Aug. 6, 2024 | Jazz Pharmaceuticals plc | $JAZZ | RIEDEL NORBERT G | Director | F | Ordinary Shares | 1484 | $111.35 | 15,952.0000 | 72,066,000 | 8.51% | 0.00% |
| Aug. 2, 2024 | Jazz Pharmaceuticals plc | $JAZZ | RIEDEL NORBERT G | Director | A | Ordinary Shares | 3731 | $0.00 | 17,436.0000 | 72,066,000 | 27.22% | 0.01% |
| Feb. 13, 2024 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | A | Stock Option (Right to buy) | 30000 | $0.00 | 164,555.0000 | 25,645,366 | 22.30% | 0.12% |
| Aug. 11, 2023 | Jazz Pharmaceuticals plc | $JAZZ | RIEDEL NORBERT G | Director | A | Ordinary Shares | 3075 | $0.00 | 14,946.0000 | 62,539,000 | 25.90% | 0.00% |
| Aug. 14, 2023 | Jazz Pharmaceuticals plc | $JAZZ | RIEDEL NORBERT G | Director | S | Ordinary Shares | 1241 | $138.16 | 13,705.0000 | 62,539,000 | 8.30% | 0.00% |
| March 3, 2023 | Eton Pharmaceuticals, Inc. | $ETON | RIEDEL NORBERT G | Director | A | Stock Option (Right to buy) | 25000 | $0.00 | 134,555.0000 | 25,146,000 | 22.82% | 0.10% |